Delivery Order SPE2DB20D7066-SPE2DB25FC1MG
Award Date
10/24/24
Potential Completion Date
10/25/24
Potential Value
$34K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $1,214.78, for the supply of NEUPOGEN 300 MCG/ML VIALML. This medical product is likely used to support military healthcare programs. The contract has a period of performance through February...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product NEUPOGEN 300 MCG/ML VIALML to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract is a Firm Fixed Price Delivery Order valued at $1,944.43, with a completion date of June 28, 2024. The contract is not set aside and was awarded on a full and open competition basis. AmerisourceBergen, a major pharmaceutical...
This federal contract award, valued at $1,214.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of NEUPOGEN 300 MCG/ML VIALML, a medical product, with a firm fixed price and an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,122.42 for the supply of the pharmaceutical product NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML. The contract has an ultimate completion date of May 16, 2024 and a firm fixed price pricing type. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,089.43 Firm Fixed Price delivery order is for the supply of Neupogen 300 mcg/mL vials, a specialty medication used to treat certain medical conditions. The contract has an ultimate completion date of September 26, 2022 and does not include any set-aside requirements, indicating it was competitively awarded....
This federal contract award is for the delivery of Neupogen 480 mcg/0.8 mL syringes to the Defense Logistics Agency (DLA). The $2,128.75 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $15,626.32 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML. This delivery order was issued under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $27,298.26, is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML pharmaceutical products. It is a Firm Fixed Price Delivery Order contract with a completion date of May 28, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $35,638.65 with a completion date of November 12, 2024. The contract is issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $46,700.21 contract is a Firm Fixed Price Delivery Order with an ultimate completion date of May 1, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...